Vistagen Therapeutics is doubling down on its lead social anxiety candidate, even after the asset...
Vistagen
With a late-stage miss reported for its prospective social anxiety disorder (SAD) treatment fasedienol, Vistagen’s...
Vistagen Therapeutics is doubling down on its lead social anxiety candidate, even after the asset...
With a late-stage miss reported for its prospective social anxiety disorder (SAD) treatment fasedienol, Vistagen’s...